We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.76B
1-Year Est. Return 62.41%
This Fund
S&P 500
This Quarter Est. Return
+3.87%
1 Year Est. Return
+62.41%
3 Year Est. Return
+179.84%
5 Year Est. Return
+371.69%
10 Year Est. Return
+1,534.25%
AUM
$4.81B
AUM Growth
-$531M
Cap. Flow
-$1.24B
Cap. Flow %
-25.85%
Top 10 Hldgs %
18.16%
Holding
673
New
167
Increased
91
Reduced
97
Closed
256
Avg Time Held Equity + Options
0.6 quarters
Top 10 Avg Time Held Equity + Options
0.6 quarters
Top 20 Avg Time Held Equity + Options
0.4 quarters
Avg Time Held Equity only
0.6 quarters
Top 10 Avg Time Held Equity only
0.6 quarters
Top 20 Avg Time Held Equity only
0.4 quarters

Top Buys

Rank Stock Value
1
CL icon
Colgate-Palmolive
CL
+$59.4M
2
ONXX
ONYX PHARMACEUTICALS INC
ONXX
+$56.3M
3
SPG icon
Simon Property Group
SPG
+$52M
4
TSM icon
TSMC
TSM
+$45.4M
5
M icon
Macy's
M
+$44.3M

Sector Composition

Rank Sector Weight
1 Miscellaneous 29.53%
2 Real Estate 16.41%
3 Consumer Staples 12.46%
4 Financials 6.75%
5 Consumer Discretionary 6.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
KO icon
276
CALL
Coca-Cola
KO
$379B
$512K 0.01%
1,000,000
– –
2013 Q2
1 quarter
FUR
277
DELISTED
WINTHROP REALTY TRUST SHS BENE INT (NEW)
FUR
$474K 0.01%
+42,500
New +$526K
2013 Q3
0 quarters
PRGN
278
DELISTED
PARAGON SHIPPING INC CL A NEW (MHL)
PRGN
$464K 0.01%
+2,114
New +$438K
2013 Q3
0 quarters
NES
279
DELISTED
NUVERRA ENVIRONMENTAL INC NEW COM STK (DE)
NES
$458K 0.01%
20,000
-15,000
-43% -$423K
2013 Q2
1 quarter
WELL.PRI icon
280
DELISTED
Welltower Inc.
WELL.PRI
$434K 0.01%
+7,500
New +$445K
2013 Q3
0 quarters
WBA icon
281
PUT
DELISTED
Walgreens Boots Alliance
WBA
$428K 0.01%
+200,000
New +$10.1M
2013 Q3
0 quarters
TWER
282
DELISTED
Towerstream Corporation Common Stock
TWER
$421K 0.01%
7,355
-1,645
-18% -$87.5K
2013 Q2
1 quarter
GS icon
283
PUT
Goldman Sachs
GS
$261B
$395K 0.01%
50,000
-21,200
-30% -$3.41M
2013 Q2
1 quarter
CCEP icon
284
CALL
Coca-Cola Europacific Partners
CCEP
$45.8B
$380K 0.01%
+200,000
New +$7.62M
2013 Q3
0 quarters
WSM icon
285
PUT
Williams-Sonoma
WSM
$28.5B
$380K 0.01%
+400,000
New +$11.6M
2013 Q3
0 quarters
BALT icon
286
DELISTED
BALTIC TRADING LIMITED COMMON STOCK
BALT
$367K 0.01%
+75,000
New +$327K
2013 Q3
0 quarters
HYG icon
287
PUT
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$17.3B
$358K 0.01%
+270,000
New +$24.8M
2013 Q3
0 quarters
SGYP
288
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
$324K 0.01%
71,929
-105,521
-59% -$473K
2013 Q2
1 quarter
RYL
289
PUT
DELISTED
RYLAND GROUP INC
RYL
$322K 0.01%
+158,800
New +$6.11M
2013 Q3
0 quarters
MDLZ icon
290
CALL
Mondelez International
MDLZ
$77.1B
$320K 0.01%
+400,000
New +$12.4M
2013 Q3
0 quarters
TXMD icon
291
TherapeuticsMD
TXMD
$23.8M
$293K 0.01%
+2,000
New +$242K
2013 Q3
0 quarters
ANTH
292
DELISTED
Anthera Pharmaceuticals, Inc.
ANTH
$291K 0.01%
9,063
-312
-3% -$9.68K
2013 Q2
1 quarter
PG icon
293
PUT
Procter & Gamble
PG
$351B
$280K 0.01%
+100,000
New +$7.96M
2013 Q3
0 quarters
M icon
294
CALL
Macy's
M
$5.92B
$265K 0.01%
+200,000
New +$9.34M
2013 Q3
0 quarters
MERU
295
DELISTED
MERU NETWORKS INC COM STK (DE)
MERU
$262K 0.01%
80,000
-55,000
-41% -$214K
2013 Q2
1 quarter
MNKD icon
296
CALL
MannKind Corp
MNKD
$1.06B
$223K ﹤0.01%
20,000
– –
2013 Q2
1 quarter
RGLS icon
297
DELISTED
Regulus Therapeutics
RGLS
$220K ﹤0.01%
+194
New +$229K
2013 Q3
0 quarters
C icon
298
CALL
Citigroup
C
$217B
$195K ﹤0.01%
385,000
+185,000
+93% +$9.35M
2013 Q2
1 quarter
STZ icon
299
CALL
Constellation Brands
STZ
$20.8B
$190K ﹤0.01%
+200,000
New +$10.9M
2013 Q3
0 quarters
WY icon
300
CALL
Weyerhaeuser
WY
$13.8B
$188K ﹤0.01%
+175,000
New +$4.95M
2013 Q3
0 quarters

Similar funds

UBS O'Connor's Q3 2013 Portfolio in Review

As of Q3 2013, UBS O'Connor held 673 positions worth $4.81B, down 9.9% from $5.34B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

UBS O'Connor withdrew a net $1.24B in Q3 2013, closing 256 positions and reducing 97 holdings. Its most notable exit was Pfizer, an estimated $167M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 30% of assets, up from 27% a quarter earlier, followed by Real Estate and Consumer Staples.

Against the trend, UBS O'Connor opened a new position in Colgate-Palmolive worth $59.4M.

  • UBS O'Connor's largest Q3 2013 buy was Colgate-Palmolive: 1,002,498 shares worth $59.4M.
  • UBS O'Connor added most to ONYX PHARMACEUTICALS INC in Q3 2013, an estimated $56.3M increase.
  • UBS O'Connor's biggest Q3 2013 reduction was Advance Auto Parts, cutting an estimated $48.2M.
  • UBS O'Connor fully exited Pfizer in Q3 2013, selling an estimated $167M.
  • UBS O'Connor's ten largest holdings make up 18% of its $4.81B portfolio in Q3 2013.
  • UBS O'Connor opened 167 new positions and closed 256 in Q3 2013.
  • UBS O'Connor's portfolio value fell 9.9% quarter-over-quarter to $4.81B.

Based on UBS O'Connor's 13F filing for Q3 2013, filed 14 Nov 2013.